ARID1A Gene Mental Retardation Autosomal Dominant Type 14 NGS Genetic DNA Test
Comprehensive Genetic Testing for Intellectual Disability
The ARID1A Gene Mental Retardation Autosomal Dominant Type 14 NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics. This advanced test utilizes next-generation sequencing technology to identify mutations in the ARID1A gene, which plays a crucial role in chromatin remodeling and gene regulation. When mutations occur in this gene, they can lead to autosomal dominant mental retardation type 14, a condition characterized by intellectual disability and developmental challenges.
What Does This Test Measure?
This comprehensive genetic analysis specifically targets:
- Detection of pathogenic variants in the ARID1A gene
- Identification of single nucleotide polymorphisms (SNPs) associated with mental retardation
- Analysis of copy number variations affecting neurological development
- Assessment of inheritance patterns for family planning purposes
- Evaluation of mutation severity and potential clinical implications
Who Should Consider This Test?
This genetic test is recommended for individuals experiencing:
- Unexplained intellectual disability or developmental delays
- Family history of autosomal dominant mental retardation
- Multiple family members with similar neurological symptoms
- Children showing signs of cognitive impairment without clear cause
- Individuals planning pregnancy with family history of neurological disorders
- Patients with suspected genetic forms of intellectual disability
Key Benefits of ARID1A Genetic Testing
- Accurate Diagnosis: Provides definitive identification of ARID1A gene mutations
- Family Planning Guidance: Helps assess inheritance risks for future generations
- Personalized Treatment: Enables targeted interventions and management strategies
- Early Intervention: Facilitates timely support services and educational planning
- Peace of Mind: Reduces uncertainty about the cause of neurological symptoms
- Comprehensive Analysis: Utilizes state-of-the-art NGS technology for thorough evaluation
Understanding Your Test Results
Your genetic test results will provide clear insights into your ARID1A gene status:
- Positive Result: Indicates the presence of a pathogenic mutation associated with mental retardation type 14. This confirms the genetic diagnosis and helps guide appropriate medical management and family counseling.
- Negative Result: Suggests no detectable mutations in the ARID1A gene. However, this doesn’t completely rule out other genetic causes of intellectual disability.
- Variant of Uncertain Significance: Some genetic changes may require additional family studies or research to determine their clinical significance.
Test Pricing Information
| Test Feature | Details |
|---|---|
| Test Name | ARID1A Gene Mental Retardation Autosomal Dominant Type 14 NGS Genetic DNA Test |
| Discount Price | $500 USD |
| Regular Price | $700 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
Nationwide Testing Availability
We have diagnostic centers conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified genetic counselors and neurological specialists ensures you receive comprehensive support throughout the testing process.
Take Control of Your Genetic Health Today
Understanding your genetic profile is the first step toward effective management of neurological conditions. Our ARID1A genetic test provides the clarity you need to make informed decisions about your health and family planning. With our discounted price of $500 USD and comprehensive analysis, you gain access to cutting-edge genetic diagnostics without financial burden.
Ready to schedule your test? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online. Our team is available to answer your questions and guide you through the testing process with compassion and expertise.
